Registry and follow‐up systems of trophoblastic disease in Japan

Kawashima, Y; Maeda, Makoto; Fujii, Toshiro

doi:10.1002/ssu.2980010204

Cited by 2 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When such a system was established in Japan in 1962, the registration center called registered patients and their doctors to remind the time of the follow‐up. This system was one of reasons which led to a decrease in the incidence of choriocarcinoma after hydatidiform mole and the mortality of choriocarcinoma was successfully reduced in Japan 31–34 . Through this system, both doctors and patients understand the importance of following up after hydatidiform mole, and the incidence of GTD is also understood.…”

Section: Discussionmentioning

confidence: 99%

“…This system was one of reasons which led to a decrease in the incidence of choriocarcinoma after hydatidiform mole and the mortality of choriocarcinoma was successfully reduced in Japan. [31][32][33][34] Through this system, both doctors and patients understand the importance of following up after hydatidiform mole, and the incidence of GTD is also understood. There are some limitations to this study.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The current situation of health services for hydatidiform mole in Cambodia

Yamamoto

Kanal²,

Soeung³

et al. 2021

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim: Management of hydatidiform mole is important to reduce the mortality and morbidity of choriocarcinoma. This study aims to understand the existing health services for hydatidiform mole and to estimate the incidence of gestational trophoblastic disease (GTD) in Cambodia. Methods: A questionnaire was used to collect information on the existing health services for pregnancy and hydatidiform mole at health facilities from attendants of the 16th Annual Conference of the Cambodian Society of Gynecology and Obstetrics in 2017. The incidence of GTD in 2014-2017 was estimated using Health Information System data. Results: A total of 126 attendants, who were from all provinces except three provinces, answered the questionnaire. The work places were national hospitals (n = 29), provincial hospitals (n = 42), district hospitals (n = 20), health centers (n = 6), and others (n = 29). The answers of participants from the public sector suggested the following: Ultrasonography is available at all hospitals but not health centers; Human chorionic gonadotropin (hCG) measurement is only available at national hospitals; Treatment of hydatidiform mole is performed at national hospitals and provincial hospitals; and Treatment of gestational trophoblastic neoplasia (GTN) is provided at national hospitals. The incidence of hydatidiform mole and GTN at health facilities in the public sector in 2014-2017 was 0.95 per 1000 deliveries and 6.58 per 100 000 deliveries, respectively. Conclusions: The results suggest that provincial hospitals are important to detect suspected invasive mole and refer to national hospitals for diagnosis and treatment. Further studies on the management of GTD and development of the guidelines of GTD are needed.

show abstract

Section: Discussionmentioning

confidence: 99%